Stay informed with the latest litigation news. Explore now
Immunogenic Composition - EP3564378B1
EP3564378
- Application Number
- EP19179871A
- Filing Date
- May 25, 2012
- Status
- Granted And Under Opposition
- Sep 29, 2023
- Grant Date
- Nov 1, 2023
- External Links
- Slate, Register, Google Patents
- Similar Patents facing opposition
Bibliography
The patent EP3564378B1 was granted to Glaxosmithkline on Nov 1, 2023 following the initial filing on May 25, 2012 under the application number EP19179871A . The current legal status of the patent is Granted And Under Opposition.
Patent Summary (AI Generated) New
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Date
Description
Get instant alerts for new documents